AngioDynamics sells dialysis and biopsy lines for $100 million in cash
CEO Jim Clemmer continues to focus the company on high-growth, next-generation products.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Robin K. Cooper Source Type: news